መነሻGRFS • NASDAQ
add
Grifols SA - ADR ADR Class B
የቀዳሚ መዝጊያ
$7.21
የቀን ክልል
$7.14 - $7.31
የዓመት ክልል
$5.79 - $9.96
የገበያው አጠቃላይ ዋጋ
5.98 ቢ USD
አማካይ መጠን
981.61 ሺ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(EUR) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 1.98 ቢ | 11.66% |
የሥራ ወጪ | 353.12 ሚ | 20.32% |
የተጣራ ገቢ | 68.97 ሚ | 76.86% |
የተጣራ የትርፍ ክልል | 3.49 | 58.64% |
ገቢ በሼር | — | — |
EBITDA | 495.68 ሚ | -11.49% |
ውጤታማ የግብር ተመን | 60.20% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(EUR) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 1.00 ቢ | 55.40% |
አጠቃላይ ንብረቶች | 21.41 ቢ | 1.97% |
አጠቃላይ ተጠያቂነቶች | 12.80 ቢ | -5.05% |
አጠቃላይ እሴት | 8.61 ቢ | — |
የሼሮቹ ብዛት | 680.41 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.83 | — |
የእሴቶች ተመላሽ | 5.08% | — |
የካፒታል ተመላሽ | 5.79% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(EUR) | ዲሴም 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 68.97 ሚ | 76.86% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 514.62 ሚ | 208.54% |
ገንዘብ ከኢንቨስትመንት | -178.31 ሚ | -28.31% |
ገንዘብ ከፋይናንስ | -27.16 ሚ | -185.08% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 334.84 ሚ | 658.87% |
ነፃ የገንዘብ ፍሰት | 162.44 ሚ | 123.56% |
ስለ
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceuticals, the company is also in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Grifols also provides biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products.
Grifols is focused on four main therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
18 ኖቬም 1940
ድህረገፅ
ሠራተኞች
23,833